Dr Gabrielle Haeusler
Department of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Childrens Hospital
Gabrielle is a peadiatric infectious diseases physician at the Royal Childrens Hospital with a special interest in kids with cancer. Gab performed her PhD in the NCIC evaluating a clinical decision rule for early oral antibiotic switch and discharge in patients who would traditionally remain in hospital for the duration of their antibiotic treatment.
Dr Brendan McMullan
Sydney Children’s Hospital
Brendan is a paediatric infectious diseases physician, microbiologist and PhD student. His research interests include antimicrobial stewardship and resistance, and infections in immunocompromised children and young people, with particular interest in utilizing surveillance data in these populations to support implementation of effective strategies to optimize antimicrobial therapy.
Congratulations to NCICKiDS team on their success with the MRFF Keeping Australians out of Hospital Scheme. The team (Lead Investigator Gabrielle Haeusler) were awarded $1.2 million to implement a home based care program for kids with cancer at low risk of febrile neutropenia. The program will be implemented nationally over the next 3 years with improvements to quality of life and significant cost savings for kids with cancer.
Paediatric Low-risk febrile neutropenia program
Free online course On paediatric fever and neutropenia
Publications and Guidelines
The Predicting Infectious ComplicatioNs In Children with Cancer (PICCNIC) study.
Project Lead : Dr Gabrielle Haeusler
Fever and neutropenia (FN), is the most common complication of the treatment of childhood cancer and the leading cause of unplanned hospital admissions. Of those children diagnosed with FN a severe infection, such as bacteraemia or pneumonia, is documented in fewer than half of all episodes. A number of paediatric clinical decision rules exist identify children at low-risk for severe infection who may qualify for reduced intensity treatment. However, due to a paucity of validation and implementation studies many centres continue to admit all children with FN for intravenous antibiotics, irrespective of underlying risk-status. This approach contributes to the over-treatment of up to half of all children with FN and has the potential to negatively impact patient and family quality of life and increase health care expenditures. The Predicting Infectious ComplicatioNs In Children with Cancer (PICCNIC) study evaluates the utility of a clinical decision rule for early oral antibiotic switch and discharge in patients who would traditionally remain in hospital for the duration of their antibiotic treatment. A sub-study in collaboration with Prof Pellegrini (WEHI) will determine potential biomarkers for inclusion into a risk prediction model.